My Medication Side Effects Are Too Popular

Not to mention billions of dollars,

Some pesticide companies feel even more heartbroken. They have worked hard for many years to increase the scale of the company. As a result, Fu Liang completely sees it.

not on the field.

But yes, who made the annual turnover of all their pharmaceutical companies combined, not as high as Fu Liang's one-year profit?

Fu Gao's Weibo has also made some domestic pesticide companies relieved, and at the same time a little disappointed.

Chapter [-]: Pesticide company frightened by Fu Liang

In the field of pesticides, nine of the top [-] companies in the world are from the East, accounting for half of the total in terms of quantity.

But from the point of view of turnover, all together, it is less than [-]% of the share, which is still more than one billion US dollars behind Bayer, the second-ranking company.

It can also be seen from this point that the development of domestic pesticide enterprises is relatively late, and the speed is relatively backward.

In fact, domestic pesticide companies, like many domestic pharmaceutical companies, lack independent research and development capabilities, and mainly produce some generic drugs.

These have no patent barriers and are easy to produce. With the advantages of labor costs and other advantages, they can make a little money, but the profit rate is far from that of the top companies.

Some domestic pesticide companies are also joint ventures, all of which are foreign companies that produce technology and produce domestically, compared to OEMs.

not much better

Like developed countries such as Europe and the United States, all companies have experienced a fight between each other, thus monopolizing the market share of a region, and then gradually developing

for international giants.

In such a comparison, domestic pharmaceutical companies are too far behind.

If Fu Gao directly enters this field, then the first thing to be eliminated is these domestic pesticide companies

These companies are also in a transition period, they have invested a lot of R&D funds, improved technology, and paid attention to patents. In fact, they do not need Fu Liang, and they can

There is international - the market breaks through a sky

That being the case, Fu Liang also- did not intend to start

But in fact, some domestic pesticide companies are still thinking of being acquired by Fu Liang, or like the two companies that have obtained patent authorization, they can follow Fu Liang.

high drink soup

Who knew that Fu Liang announced that he would not do pesticides, and it also made their abacus empty.

Although Fu Gao announced,

, but many people do not quite believe it.

Some directors were sitting there, debating whether to continue to increase the R&D investment of Bayer CropScience, a pesticide subsidiary.

Bayer corporate headquarters,

"Everyone, I don't think we need to continue to increase investment. If Fu Liang enters the field of pesticides, all our research and development funds will be wasted.

"I'm not saying that we don't continue to invest, it's just that we don't increase, we can upgrade the formula of some of the current advantageous products, and still guarantee

our market share.

As soon as the director finished speaking, the director immediately objected

"Fu Liang has announced that he will not enter the field of pesticides. If we do not increase, it will be impossible to catch up with Syngenta and sit on the throne of the No. [-] pesticide company.

"Our sales with Syngenta have exceeded [-] billion US dollars,

, although the gap is not large, but it has not been able to exceed.

"As long as we increase investment in research and development in the field of insecticide and weed control, and successfully develop one or two new drugs, we will become the world's first. This is a good opportunity for us

To miss out? What's the point of holding on to the previous years?'

The chairman suddenly said: "What if Fu Liang is just talking? Who can guarantee that he will not enter the pesticide field? Don't forget how much they made this time.

"Although the cost announced by the East is very high, we can probably calculate how much the cost actually is. They must be making huge profits.

Want to miss out on a lucrative industry?

"Besides, although he is already in the top ten of the rich list, he is not the first, so he doesn't want to reach the top this year?"

Although it is said that the high-paying Chu Woqing made a lot of money this time, it is accidental, but in fact, every few years, this kind of thing will happen.

It is that some pests and diseases have developed resistance to common pesticides, which is not so easy to kill.

production reduction.

Every time at this time, it is a time for major pesticide companies to compete, to see who can first develop pesticides with better effects, who can occupy this market and improve

Increase your sales.

But the research and development speed of major pesticide companies was not fast before. Under normal circumstances, they also have all preparations.

For example, Baidou occupies a dominant position in the field of crop germs. Their old drugs are still selling well, so they don’t need to bring new ones to the market.

Because the introduction of new models means that the production line needs to be adjusted and re-promoted, which increases costs and reduces profits.

Unless there is a competitor, or the old drug is not working well, they will bring the latest pesticide to the market and continue to occupy the market.

market share.

At that time there were only a few competitors, and they were not afraid of the challenges of other companies, but now it is different, with Fu Liang.

V wins

If drug resistance occurs again, their new pesticides may have just started production, and Fu Liang announced that they have developed better pesticides. How can they

At that time, will those farmers buy them, or buy Fu Liang?

If the effect is similar, they can still have the upper hand by virtue of the advantages of sales channels, but what if Fu Liang's effect is better?

Or what about the lower cost and lower price of the medicines developed by Pay Gao?

Either way, it means they will fail, lose a lot of market share, and waste their R&D expenses.

Originally, after seeing the rapid development of pesticide companies in the East this year, the major pesticide companies were ready to increase their R&D investment after grabbing some of their market share.

How about defeating the pesticide companies in the East?

But because of the appearance of Fu Liang, they suddenly stopped increasing their research and development funds, which also gave many opportunities for pesticide companies in the east to continue to grow.

They may not have imagined that other pesticide companies chose this because they were afraid of Fu Liang.

Fear of Fu Liang, who has announced that he does not look down on the profits of pesticides.

And these, Fu Liang also did not know.

He put his energy back into the field of human medicine, continued to check the formula of Chinese patent medicine, and wanted to find more suitable and improved new special effects in it.

There is a cancer field in front of him. He has solved the twenty types of cancer with the highest fatality rate, but there are actually many cancers, which belong to the niche category. Fu Liang also

Hundred did not give up.

He promised that he would develop some medicines for the treatment of niche pain. This is not only his promise, but also his long-cherished wish.

Others will lose money when they develop medicines for niche pain.

Zhiqian said that in the future, the special drugs he developed will monopolize the market, and it is unlikely for the time being.

There are more than [-] known diseases in the world, and Fu Liang has only developed dozens of new drugs, which is far from enough, so he never worries about his own drugs.

Penalized for monopoly.

Countries did not dare to punish them, for fear that Fu Liang would develop any new special medicine and not sell it to them.

After working hard for half a month, Fu Liang finally smiled when he was looking at a prescription.Down

Report

Reward

Chapter two hundred and sixty-fifth: start to attack niche cancer

Makeup is a drug used to treat arthritis with dryness, but after the second phase of the clinical trial, it was found that the effect was too poor, so the research and development was stopped.

But in the side effects, Fu Liang discovered the side effects of killing melanoma tumor cells!

A relatively small form of cancer, commonly seen in white or middle-aged and elderly people.

melanoma,

Usually it is not easy to find, and when it is generally found, it is already late.

In addition, the tumor cells will also metastasize to the liver, lung, bone, brain and other places, and can also cause symptoms such as glaucoma and retinal detachment.

This kind of cancer may not have been heard of by many people in China because it is too rare.

The overall year-on-year disease rate also accounts for % of skin pain-

"The system, amplifies the side effects of this drug in killing melanoma tumor cells by 81920 times.

[The host specified to amplify the side effects of the drug "81920" in killing melanoma cells by [-] times, are you sure?]

"Sure!

[The host consumes 8192000 energy points, and successfully amplifies the side effects of this drug in killing melanoma cells by 81920 times. 】

[The fine-tuned formulation of the drug has been generated, and the side effect of killing melanoma cells is expected to be a super high incidence side effect, and the probability of this side effect will reach 99.9%

9%!]

[Please let the host use the medicine to more people as soon as possible. According to the feedback from the user, a large number of energy points can be obtained. 】

Fu Gao looked at the fine-tuned formula with an irresistible smile on his face.

His first cure for a niche cancer was finally developed

In fact, many pharmaceutical companies are now saying that cancer treatment has entered a niche era.